May 30, 2013
Eisai on May 29 launched the antiepileptic treatment Inovelon Tablets 100 mg and 200 mg (rufinamide) as an adjunctive therapy to other antiepileptic drugs in the treatment of Lennox-Gastaut syndrome (LGS). The NHI price is set at 79.70 yen per...read more